Showing results (711-720 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|December 23, 2010
Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatinMichael A Gordon, Wu Zhang, Dongyun Yang, et al.
Pharmacogenomics|December 23, 2010
How can we identify parasite genes that underlie antimalarial drug resistance?Tim Anderson, Standwell Nkhoma, Andrea Ecker, et al.
Pharmacogenomics|July 7, 2010
A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivativesTalitha I Verhoef, William K Redekop, Josep Darba, et al.
Pharmacogenomics|November 5, 2010
Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipientsPing Wang, Yong Mao, Juan Razo, et al.
Pharmacogenomics|September 24, 2010
Pharmacogenomic strategies against microbial resistance: from bright to bleak to innovativeThomas Dandekar, Gudrun Dandekar
Pharmacogenomics|February 22, 2011
Institutional Profile: University of California San Diego Pharmacogenomics Education Program (PharmGenEd™): bridging the gap between science and practiceGrace M Kuo, Joseph D Ma, Kelly C Lee, et al.
Pharmacogenomics|February 22, 2011
Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarkerAyelet Morag, Metsada Pasmanik-Chor, Varda Oron-Karni, et al.
Pharmacogenomics|February 22, 2011
5-Fluorouracil pharmacogenomics: still rocking after all these years?Mario Scartozzi, Elena Maccaroni, Riccardo Giampieri, et al.
Pharmacogenomics|February 22, 2011
Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine responseRudi Hwang, Renan P Souza, Arun K Tiwari, et al.
Pharmacogenomics|April 1, 2011
Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsyPatrick Kwan, Virginia Wong, Ping Wing Ng, et al.
Pageof 276